Answers are grounded in this paper and cite their sources.
Liver resection remains one of the most important option in combined treatment for liver tumors; however, it harbors the risk of developing posthepatectomy liver failure. The principal risk is associated with the quality and quantity of the future remnant liver. Therefore, preoperative assessment of the future remnant liver is essential in patients scheduled for major hepatectomy. Technetium-99m-mebrofenin hepatobiliary scintigraphy is increasingly applied for the quantitative assessment of liver function before major liver resection.
No takes yet. Share an insight, caveat, or question.
Likar et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: